Literature DB >> 2163594

Autoimmune mechanisms in peripheral neuropathies.

R K Yu1, T Ariga, T Kohriyama, S Kusunoki, Y Maeda, N Miyatani.   

Abstract

In certain patients with demyelinating neuropathy and plasma cell dyscrasia, there are IgM monoclonal antibodies that recognize a carbohydrate epitope shared by myelin-associated glycoprotein (MAG) and at least two acidic glycolipids in the peripheral nervous system (PNS). The structures of the two acidic lipids have been elucidated as a new class of glycosphingolipids, termed sulfoglucuronyl glycolipids (SGGLs). SGGLs have been demonstrated to be present in myelin, axolemma, and other glia-related membranes in PNS of several animal species, as well as in human dorsal root ganglia and sympathetic ganglia. In rabbits sensitized with sulfoglucuronyl paragloboside (SGPG), a major SGGL in PNS, antibodies developed with reactivities toward SGPG and MAG. The animals also showed moderate weakness, a slowed nerve conduction velocity, and evidence of conduction block. Recently we also found SGPG in rat brain microvessels. This finding supports our hypothesis that autoantibodies may first interact with endothelial cell-bound antigens and that this might change the permeability of the blood-brain or blood-nerve barrier to permit the entry of these autoantibodies into the nervous system. Our data are consistent with the concept that an autoimmune response against the sulfoglucuronyl residue may participate in the pathogenesis of immune-mediated neuropathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2163594     DOI: 10.1002/ana.410270709

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Diabetic neuropathy in older adults.

Authors:  Kara A Witzke; Aaron I Vinik
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 2.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

3.  Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia.

Authors:  M Arai; H Yoshino; Y Kusano; Y Yazaki; Y Ohnishi; T Miyatake
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

4.  Interleukin 1 beta up-regulates the expression of sulfoglucuronosyl paragloboside, a ligand for L-selectin, in brain microvascular endothelial cells.

Authors:  T Kanda; M Yamawaki; T Ariga; R K Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Immunoelectron microscopic localization of monoclonal IgM antibodies in gammopathy associated with peripheral demyelinative neuropathy.

Authors:  B Lach; P Rippstein; D Atack; D E Afar; A Gregor
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

Review 6.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995

7.  Glycosphingolipid antigens in cultured bovine brain microvascular endothelial cells: sulfoglucuronosyl paragloboside as a target of monoclonal IgM in demyelinative neuropathy [corrected].

Authors:  T Kanda; H Yoshino; T Ariga; M Yamawaki; R K Yu
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

8.  Anti-Sulfoglucuronosyl Paragloboside Antibody: A Potential Serologic Marker of Amyotrophic Lateral Sclerosis.

Authors:  Dongpei Li; Seigo Usuki; Brandy Quarles; Michael H Rivner; Toshio Ariga; Robert K Yu
Journal:  ASN Neuro       Date:  2016-09-28       Impact factor: 4.146

9.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

Review 10.  Complex carbohydrates in drug development.

Authors:  R L Schnaar
Journal:  Adv Pharmacol       Date:  1992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.